A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential
Abstract: Under different pathological conditions, aberrant induction of neuronal nitric oxide synthase (nNOS) generates overproduction of NO that can cause irreversible cell damage. The aim of this study was to develop an amidoxime prodrug of a potent nNOS inhibitor, the benzhydryl acetamidine. We synthesized the benzhydryl acetamidoxime, which was evaluated in vitro to ascertain the potential NOS inhibitory activity, as well as conducting bioconversion into the parent acetamidine. The prodrug was also profiled for in vitro physicochemical properties, by determining the lipophilicity, passive permeation through the human gastrointestinal tract and across the blood‐brain barrier by PAMPA, and chemical, enzymatic, and plasma stability. The obtained data demonstrate that the amidoxime prodrug shows an improved pharmacokinetic profile with respect to the acetamidine nNOS inhibitor, thus suggesting that it could be a promising lead compound to treat all those pathological conditions in which nNOS activity is dysregulated.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential ; volume:15 ; number:22 ; year:2020 ; pages:2157-2163 ; extent:7
ChemMedChem ; 15, Heft 22 (2020), 2157-2163 (gesamt 7)
- Urheber
-
Maccallini, Cristina
Marinelli, Lisa
Indorf, Patrick
Cacciatore, Ivana
Fantacuzzi, Marialuigia
Clement, Bernd
Di Stefano, Antonio
Amoroso, Rosa
- DOI
-
10.1002/cmdc.202000349
- URN
-
urn:nbn:de:101:1-2022062512094668673877
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Maccallini, Cristina
- Marinelli, Lisa
- Indorf, Patrick
- Cacciatore, Ivana
- Fantacuzzi, Marialuigia
- Clement, Bernd
- Di Stefano, Antonio
- Amoroso, Rosa
Ähnliche Objekte (12)
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential
A Phosphoramidate Prodrug Platform: One‐Pot Amine Functionalization of Kinase Inhibitors with Oligoethylene Glycol for Improved Water‐Solubility
Development and Pharmacokinetic Evaluation of Two Parenteral Formulations of Albendazole Using Prodrug and Cosolvent Approaches
Zap‐Pano: a Photocaged Prodrug of the KDAC Inhibitor Panobinostat
Cephalosporin Prodrug Inhibitors Overcome Metallo‐β‐Lactamase Driven Antibiotic Resistance
Hypoxia‐Responsive Prodrug of ATR Inhibitor, AZD6738, Selectively Eradicates Treatment‐Resistant Cancer Cells
Neue Prodrug-Prinzipien für Amidine
Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis
Novel glycosyl prodrug of RXP03 as MMP-11 prodrug: design, synthesis and virtual screening
A polymeric colchicinoid prodrug with reduced toxicity and improved efficacy for vascular disruption in cancer therapy
Prodrug-Activating Chain Exchange (PACE) converts targeted prodrug derivatives to functional bi- or multispecific antibodies
Prodrug-based nanomedicines for rheumatoid arthritis
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential
A Phosphoramidate Prodrug Platform: One‐Pot Amine Functionalization of Kinase Inhibitors with Oligoethylene Glycol for Improved Water‐Solubility
Development and Pharmacokinetic Evaluation of Two Parenteral Formulations of Albendazole Using Prodrug and Cosolvent Approaches
Zap‐Pano: a Photocaged Prodrug of the KDAC Inhibitor Panobinostat
Cephalosporin Prodrug Inhibitors Overcome Metallo‐β‐Lactamase Driven Antibiotic Resistance
Hypoxia‐Responsive Prodrug of ATR Inhibitor, AZD6738, Selectively Eradicates Treatment‐Resistant Cancer Cells
Neue Prodrug-Prinzipien für Amidine
Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis
Novel glycosyl prodrug of RXP03 as MMP-11 prodrug: design, synthesis and virtual screening
A polymeric colchicinoid prodrug with reduced toxicity and improved efficacy for vascular disruption in cancer therapy
Prodrug-Activating Chain Exchange (PACE) converts targeted prodrug derivatives to functional bi- or multispecific antibodies
Prodrug-based nanomedicines for rheumatoid arthritis
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential
A Phosphoramidate Prodrug Platform: One‐Pot Amine Functionalization of Kinase Inhibitors with Oligoethylene Glycol for Improved Water‐Solubility
Development and Pharmacokinetic Evaluation of Two Parenteral Formulations of Albendazole Using Prodrug and Cosolvent Approaches
Zap‐Pano: a Photocaged Prodrug of the KDAC Inhibitor Panobinostat
Cephalosporin Prodrug Inhibitors Overcome Metallo‐β‐Lactamase Driven Antibiotic Resistance
Hypoxia‐Responsive Prodrug of ATR Inhibitor, AZD6738, Selectively Eradicates Treatment‐Resistant Cancer Cells
Neue Prodrug-Prinzipien für Amidine
Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis
Novel glycosyl prodrug of RXP03 as MMP-11 prodrug: design, synthesis and virtual screening
A polymeric colchicinoid prodrug with reduced toxicity and improved efficacy for vascular disruption in cancer therapy
Prodrug-Activating Chain Exchange (PACE) converts targeted prodrug derivatives to functional bi- or multispecific antibodies